Kala Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This SDG rating for Kala Pharmaceuticals Inc represents the company's reporting of the UN Sustainable Development Goals. Full Sustainability analysis of Kala Pharmaceuticals Inc can be reached by signing in. Alternative companies in the scoring industry group for Kala Pharmaceuticals Inc are shown.
Kala Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.0; made up of an environmental score of 5.3, social score of 1.6 and governance score of 8.0.
5.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 724 | Skye Bioscience Inc | 5.1 | High |
| 724 | Xbrane Biopharma AB | 5.1 | High |
| 744 | Kala Pharmaceuticals Inc | 5.0 | High |
| 744 | CSL Ltd | 5.0 | High |
| 744 | CStone Pharmaceuticals | 5.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Kala Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Kala Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Kala Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Kala Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Kala Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Kala Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Kala Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Kala Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development products comprise KPI-287 that inhibits the vascular endothelial and platelet derived growth factors for the treatment of retinal diseases, including wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion; and selective glucocorticoid receptor modulators program, a novel class of compounds to regulate gene expression through the transrepression pathway while avoiding the transactivation pathway. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Watertown, Massachusetts.